Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $360.93 | 4 | 65.7% |
| Education | $157.03 | 6 | 28.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $31.25 | 1 | 5.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $120.31 | 1 | $0 (2018) |
| Myriad Genetic Laboratories, Inc. | $119.20 | 1 | $0 (2021) |
| Allergan Inc. | $107.40 | 1 | $0 (2019) |
| Incyte Corporation | $95.95 | 1 | $0 (2018) |
| Seattle Genetics, Inc. | $49.16 | 4 | $0 (2019) |
| PFIZER INC. | $31.25 | 1 | $0 (2018) |
| Genentech USA, Inc. | $14.02 | 1 | $0 (2017) |
| Gilead Sciences, Inc. | $11.92 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $131.12 | 2 | Myriad Genetic Laboratories, Inc. ($119.20) |
| 2019 | $119.69 | 2 | Allergan Inc. ($107.40) |
| 2018 | $284.38 | 6 | AstraZeneca Pharmaceuticals LP ($120.31) |
| 2017 | $14.02 | 1 | Genentech USA, Inc. ($14.02) |
All Payment Transactions
11 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/05/2021 | Myriad Genetic Laboratories, Inc. | myRisk (Device) | Food and Beverage | Cash or cash equivalent | $119.20 | General |
| Category: Germline DNA Sequencing Hereditary Cancer and Rearrangement Analysis | ||||||
| 06/01/2021 | Gilead Sciences, Inc. | — | Education | In-kind items and services | $11.92 | General |
| 10/15/2019 | Allergan Inc. | NATRELLE (Device) | Food and Beverage | In-kind items and services | $107.40 | General |
| Category: PLASTICS | ||||||
| 02/15/2019 | Seattle Genetics, Inc. | ADCETRIS (Biological) | Education | In-kind items and services | $12.29 | General |
| Category: Oncology | ||||||
| 11/06/2018 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $120.31 | General |
| 08/28/2018 | Seattle Genetics, Inc. | ADCETRIS (Biological) | Education | In-kind items and services | $12.29 | General |
| Category: Oncology | ||||||
| 08/09/2018 | Seattle Genetics, Inc. | ADCETRIS (Biological) | Education | In-kind items and services | $12.29 | General |
| Category: Oncology | ||||||
| 06/30/2018 | PFIZER INC. | BOSULIF (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $31.25 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 04/09/2018 | Seattle Genetics, Inc. | ADCETRIS (Biological) | Education | In-kind items and services | $12.29 | General |
| Category: Oncology | ||||||
| 03/16/2018 | Incyte Corporation | — | Education | Cash or cash equivalent | $95.95 | General |
| 08/15/2017 | Genentech USA, Inc. | GAZYVA (Biological), Rituxan | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: BioOncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 37 | 1,441 | 4,956 | $529,895 | $109,648 |
| 2022 | 54 | 1,906 | 48,970 | $2.2M | $515,726 |
| 2021 | 65 | 2,501 | 38,907 | $2.8M | $708,464 |
| 2020 | 64 | 2,638 | 42,198 | $2.5M | $552,822 |
All Medicare Procedures & Services
220 procedure records from CMS Medicare Utilization — Page 1 of 9
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 188 | 264 | $79,686 | $24,366 | 30.6% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 12 | 1,080 | $76,200 | $19,898 | 26.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 96 | 151 | $57,167 | $19,468 | 34.1% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 42 | 88 | $73,433 | $8,479 | 11.5% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 17 | 75 | $18,687 | $4,158 | 22.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 28 | 36 | $10,590 | $3,285 | 31.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 16 | 16 | $9,280 | $2,692 | 29.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 108 | 319 | $11,165 | $2,428 | 21.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 35 | 35 | $6,319 | $2,190 | 34.7% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 32 | 43 | $13,072 | $2,148 | 16.4% |
| 83520 | Measurement of substance using immunoassay technique | Office | 2023 | 26 | 128 | $23,168 | $2,141 | 9.2% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 75 | 184 | $11,408 | $1,904 | 16.7% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 79 | 127 | $7,366 | $1,697 | 23.0% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2023 | 36 | 134 | $14,070 | $1,544 | 11.0% |
| 86334 | Immunologic analysis technique on serum (immunofixation) | Office | 2023 | 28 | 69 | $10,695 | $1,510 | 14.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 91 | 176 | $3,344 | $1,478 | 44.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 57 | 113 | $10,509 | $1,208 | 11.5% |
| 83550 | Iron binding capacity | Office | 2023 | 78 | 123 | $4,182 | $1,054 | 25.2% |
| 96417 | Administration of additional new drug or substance into vein, 1 hour or less | Office | 2023 | 13 | 17 | $6,921 | $806.08 | 11.6% |
| 83540 | Iron level | Office | 2023 | 78 | 123 | $3,198 | $779.82 | 24.4% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 11 | 11 | $1,848 | $774.29 | 41.9% |
| 82784 | Gammaglobulin (immune system protein) measurement | Office | 2023 | 16 | 81 | $4,374 | $738.18 | 16.9% |
| 84165 | Protein measurement, serum | Office | 2023 | 28 | 69 | $6,624 | $726.57 | 11.0% |
| 96360 | Infusion into a vein for hydration, 31-60 minutes | Office | 2023 | 22 | 27 | $6,723 | $688.77 | 10.2% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2023 | 15 | 29 | $4,408 | $633.64 | 14.4% |
About Dr. Ranjit Goudar, M.D
Dr. Ranjit Goudar, M.D is a Hematology & Oncology healthcare provider based in Norfolk, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/09/2007. The National Provider Identifier (NPI) number assigned to this provider is 1467584383.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ranjit Goudar, M.D has received a total of $549.21 in payments from pharmaceutical and medical device companies, with $131.12 received in 2021. These payments were reported across 11 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($360.93).
As a Medicare-enrolled provider, Goudar has provided services to 8,486 Medicare beneficiaries, totaling 135,031 services with total Medicare billing of $1.9M. Data is available for 4 years (2020–2023), covering 220 distinct procedure/service records.
Practice Information
- Specialty Hematology & Oncology
- Other Specialties Hematology & Oncology
- Location Norfolk, VA
- Active Since 03/09/2007
- Last Updated 04/26/2011
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1467584383
Products in Payments
- myRisk (Device) $119.20
- NATRELLE (Device) $107.40
- ADCETRIS (Biological) $49.16
- BOSULIF (Drug) $31.25
- GAZYVA (Biological) $14.02
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Norfolk
Rabih Fahed, M.d, M.D
Hematology & Oncology — Payments: $337,010
Gary Simmons, Do, DO
Hematology & Oncology — Payments: $66,315
Michael Danso, M.d, M.D
Hematology & Oncology — Payments: $54,407
Dr. Shanley Banaag, D.o, D.O
Hematology & Oncology — Payments: $3,419
Thomas Alberico, Md, MD
Hematology & Oncology — Payments: $572.79
Boon Cheng Kok, Md, MD
Hematology & Oncology — Payments: $539.63